Literature DB >> 20949383

The need to downregulate: a minimal ethical framework for biobank research.

Mats G Hansson1.   

Abstract

There are currently multiple international bodies suggesting legal and ethical frameworks for regulating international biobank research. One will for obvious reasons find inconsistencies in terminology and differences in procedures suggested for biobank research among all those guidelines, emanating from many different moral and legal traditions. A central question is whether this constitutes a threat to making progress in international biobank research, as some have argued. In this book, Chapter 1 suggests that there are sufficient and well-established instruments and ethical principles available to guide research in this area. Basically I argue that there is no need for a top-down superstructure of detailed rules and guidelines to be imposed on biobank researchers. With the existing ethical review boards (ERBs) playing a central role guided by well-established ethical guidelines (e.g., the Helsinki Declaration) and solutions to specific ethical problems suggested in the literature, self-regulation by researchers providing arguments for balancing of interests in association with different research initiatives and protocols will be sufficient. Traditional information and consent procedures suffice and data protection implies a sovereign right of the individual citizen to grant the use of biobank material and personal data that is needed for biobank research. Clearly, there may still be inconsistencies in terminology when researchers of different nationalities meet in common enterprises, but both they and the ERBs are well equipped to sort out what is actually meant and propose different instruments for, for example, coding following recently established nomenclatures. The existing ERBs should play the key role, guided by the sound argumentation of the researchers in their applications to the board.

Mesh:

Year:  2011        PMID: 20949383     DOI: 10.1007/978-1-59745-423-0_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  Sustainability in Biobanking.

Authors:  Maram Abdaljaleel; Elyse J Singer; William H Yong
Journal:  Methods Mol Biol       Date:  2019

2.  Patient/family views on data sharing in rare diseases: study in the European LeukoTreat project.

Authors:  Sylviane Darquy; Grégoire Moutel; Anne-Sophie Lapointe; Diane D'Audiffret; Julie Champagnat; Samia Guerroui; Marie-Louise Vendeville; Odile Boespflug-Tanguy; Nathalie Duchange
Journal:  Eur J Hum Genet       Date:  2015-06-17       Impact factor: 4.246

3.  Researchers' Perspectives on Informed Consent and Ethical Review of Biobank Research in South Africa: A Cross-Sectional Study.

Authors:  Erisa Mwaka; Lyn Horn
Journal:  J Empir Res Hum Res Ethics       Date:  2019-08-05       Impact factor: 1.742

Review 4.  Ethical aspects of human biobanks: a systematic review.

Authors:  Danijela Budimir; Ozren Polasek; Ana Marusić; Ivana Kolcić; Tatijana Zemunik; Vesna Boraska; Ana Jeroncić; Mladen Boban; Harry Campbell; Igor Rudan
Journal:  Croat Med J       Date:  2011-06       Impact factor: 1.351

5.  Current Status and Future Challenges of Biobank Research in Malaysia.

Authors:  Latifah Amin; Angelina Olesen; Zurina Mahadi; Maznah Ibrahim
Journal:  Asian Bioeth Rev       Date:  2021-03-31

6.  Gene mutations responsible for primary immunodeficiency disorders: A report from the first primary immunodeficiency biobank in Iran.

Authors:  Saba Sheikhbahaei; Roya Sherkat; Dirk Roos; Majid Yaran; Somayeh Najafi; Alireza Emami
Journal:  Allergy Asthma Clin Immunol       Date:  2016-12-02       Impact factor: 3.406

7.  Sickle Cell Disease Genomics of Africa (SickleGenAfrica) Network: ethical framework and initial qualitative findings from community engagement in Ghana, Nigeria and Tanzania.

Authors:  Kofi A Anie; Edeghonghon Olayemi; Vivian Paintsil; Ellis Owusu-Dabo; Titilope Adenike Adeyemo; Mahmoud U Sani; Najibah Aliyu Galadanci; Obiageli Nnodu; Furahini Tluway; David Nana Adjei; Peter Mensah; Joseph Sarfo-Antwi; Henry Nwokobia; Awwal Gambo; Adebola Benjamin; Arafa Salim; Judith A Osae-Larbi; Solomon Fiifi Ofori-Acquah
Journal:  BMJ Open       Date:  2021-07-23       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.